Fetal and Neonatal Effects of Maternal Drug Treatment for Depression

Seminars in Perinatology

Volumn 32, Issue 5, 2008, Pages 350-354

  Belik, Jaques ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

fluoxetine; pulmonary hypertension; selective serotonin reuptake inhibitors

Indexed keywords

FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

AGITATION; ARTICLE; CLINICAL FEATURE; COGNITION; CYANOSIS; DEPRESSION; DIARRHEA; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTHERMIA; HYPOTHERMIA; IRRITABILITY; LOW BIRTH WEIGHT; MUSCLE TONE; NERVOUSNESS; NONHUMAN; NOSE CONGESTION; PATHOLOGICAL REFLEX; PREGNANCY; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS; RESPIRATORY TRACT DISEASE; RESTLESS SLEEP; SHEEP; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; SUCKING; TACHYPNEA; TREMOR; VOMITING;

EID: 52949127028     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2008.08.001     Document Type: Article

References (39)

1. Belmaker R.H., and Agam G. Major depressive disorder. N Engl J Med 358 (2008) 55-68
2. World Health Organization (2008). www.whoint/mental_health/management/depression/definition/en
3. Vasiliadis H.M., Lesage A., Adair C., et al. Do Canada and the United States differ in prevalence of depression and utilization of services?. Psychiatr Serv 58 (2007) 63-71
4. Merikangas K.R., Ames M., Cui L., et al. The impact of comorbidity of mental and physical conditions on role disability in the US adult household population. Arch Gen Psychiatry 64 (2007) 1180-1188
5. Kessler R.C., Berglund P., Demler O., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289 (2003) 3095-3105
6. Austin M.P., Kildea S., and Sullivan E. Maternal mortality and psychiatric morbidity in the perinatal period: challenges and opportunities for prevention in the Australian setting. Med J Aust 186 (2007) 364-367
7. Lattimore K.A., Donn S.M., Kaciroti N., et al. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis. J Perinatol 25 (2005) 595-604
8. Austin M.P. To treat or not to treat: maternal depression. SSRI use in pregnancy and adverse neonatal effects. Psychol Med 36 (2006) 1663-1670
9. Andrade S.E., Raebel M.A., Morse A.N., et al. Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol Drug Saf 15 (2006) 546-554
10. Lawrenson R.A., Tyrer F., Newson R.B., et al. The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared. J Affect Disord 59 (2000) 149-157
11. Einarson T.R., and Einarson A. Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf 14 (2005) 823-827
12. Rahimi R., Nikfar S., and Abdollahi M. Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials. Reprod Toxicol 22 (2006) 571-575
13. Hendrick V., Stowe Z.N., Altshuler L.L., et al. Placental passage of antidepressant medications. Am J Psychiatry 160 (2003) 993-996
14. Chambers C.D., Johnson K.A., Dick L.M., et al. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 335 (1996) 1010-1015
15. Kulin N.A., Pastuszak A., Sage S.R., et al. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA 279 (1998) 609-610
16. Ortiz J., and Artigas F. Effects of monoamine uptake inhibitors on extracellular and platelet 5-hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetine. Br J Pharmacol 105 (1992) 941-946
17. Alvarez J.C., Sanceaume M., Advenier C., et al. Differential changes in brain and platelet 5-HT concentrations after steady-state achievement and repeated administration of antidepressant drugs in mice. Eur Neuropsychopharmacol 10 (1999) 31-36
18. Alvarez J.C., Gluck N., Arnulf I., et al. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine. Clin Pharmacol Ther 66 (1999) 617-624
19. Fornaro E., Li D., Pan J., et al. Prenatal exposure to fluoxetine induces fetal pulmonary hypertension in the rat. Am J Respir Crit Care Med 176 (2007) 1035-1040
20. Morrison J.L., Chien C., Riggs K.W., et al. Effect of maternal fluoxetine administration on uterine blood flow, fetal blood gas status, and growth. Pediatr Res 51 (2002) 433-442
21. Morrison J.L., Chien C., Gruber N., et al. Fetal behavioural state changes following maternal fluoxetine infusion in sheep. Brain Res Dev Brain Res 131 (2001) 47-56
22. Morrison J.L., Riggs K.W., Chien C., et al. Chronic maternal fluoxetine infusion in pregnant sheep: effects on the maternal and fetal hypothalamic-pituitary-adrenal axes. Pediatr Res 56 (2004) 40-46
23. Morrison J.L., Riggs K.W., and Rurak D.W. Fluoxetine during pregnancy: impact on fetal development. Reprod Fertil Dev 17 (2005) 641-650
24. Chambers C.D., Hernandez-Diaz S., Van Marter L.J., et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354 (2006) 579-587
25. de Caestecker M. Serotonin signaling in pulmonary hypertension. Circ Res 98 (2006) 1229-1231
26. Guignabert C., Raffestin B., Benferhat R., et al. Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats. Circulation 111 (2005) 2812-2819
27. Marcos E., Adnot S., Pham M.H., et al. Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension. Am J Respir Crit Care Med 168 (2003) 487-493
28. Kawut S.M., Horn E.M., Berekashvili K.K., et al. Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension. Pulm Pharmacol Ther 19 (2006) 370-374
29. Hernandez-Diaz S., Van Marter L.J., Werler M.M., et al. Risk factors for persistent pulmonary hypertension of the newborn. Pediatrics 120 (2007) e272-e282
30. Ghamra Z.W., and Dweik R.A. Primary pulmonary hypertension: an overview of epidemiology and pathogenesis. Cleve Clin J Med 70 (2003) S2-S8 (suppl 1)
31. Smith A.M., Jones R.D., and Channer K.S. The influence of sex hormones on pulmonary vascular reactivity: possible vasodilator therapies for the treatment of pulmonary hypertension. Curr Vasc Pharmacol 4 (2006) 9-15
32. Moses-Kolko E.L., Bogen D., Perel J., et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 293 (2005) 2372-2383
33. Levinson-Castiel R., Merlob P., Linder N., et al. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 160 (2006) 173-176
34. Oberlander T.F., Warburton W., Misri S., et al. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 63 (2006) 898-906
35. Gentile S., Rossi A., and Bellantuono C. SSRIs during breastfeeding: spotlight on milk-to-plasma ratio. Arch Womens Ment Health 10 (2007) 39-51
36. Brandon A.R., Trivedi M.H., Hynan L.S., et al. Prenatal depression in women hospitalized for obstetric risk. J Clin Psychiatry 69 (2008) 635-643
37. Qiu C., Sanchez S.E., Lam N., et al. Associations of depression and depressive symptoms with preeclampsia: results from a Peruvian case-control study. BMC Womens Health 7 (2007) 15
38. Cox J.L., Holden J.M., and Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 150 (1987) 782-786
39. Sanderson C.A., Cowden B., Hall D.M., et al. Is postnatal depression a risk factor for sudden infant death?. Br J Gen Pract 52 (2002) 636-640